BG63975B1 - Бензопиранопиролови и бензопиранопиридинови алфа-1 адренергични съединения - Google Patents

Бензопиранопиролови и бензопиранопиридинови алфа-1 адренергични съединения Download PDF

Info

Publication number
BG63975B1
BG63975B1 BG103553A BG10355399A BG63975B1 BG 63975 B1 BG63975 B1 BG 63975B1 BG 103553 A BG103553 A BG 103553A BG 10355399 A BG10355399 A BG 10355399A BG 63975 B1 BG63975 B1 BG 63975B1
Authority
BG
Bulgaria
Prior art keywords
butyl
benzopyran
compound
pyrrol
group
Prior art date
Application number
BG103553A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103553A (en
Inventor
Michael Meyer
Robert Altenbach
Fatima Basha
William Carroll
Irene Drizin
James KERWIN
Michael Wendt
Anthony HAIGHT
Weijiang Zhang
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/980,130 external-priority patent/US6046207A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG103553A publication Critical patent/BG103553A/xx
Publication of BG63975B1 publication Critical patent/BG63975B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
BG103553A 1996-12-06 1999-07-05 Бензопиранопиролови и бензопиранопиридинови алфа-1 адренергични съединения BG63975B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76142396A 1996-12-06 1996-12-06
US08/980,130 US6046207A (en) 1996-12-06 1997-11-26 Benzopyranopyrrole and benzopyranopyridine α-1 adrenergic compounds
PCT/US1997/022279 WO1998024791A1 (en) 1996-12-06 1997-12-04 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds

Publications (2)

Publication Number Publication Date
BG103553A BG103553A (en) 2000-06-30
BG63975B1 true BG63975B1 (bg) 2003-08-29

Family

ID=27116981

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103553A BG63975B1 (bg) 1996-12-06 1999-07-05 Бензопиранопиролови и бензопиранопиридинови алфа-1 адренергични съединения

Country Status (19)

Country Link
EP (1) EP0942911B1 (cs)
JP (1) JP2002504088A (cs)
KR (1) KR20000057418A (cs)
CN (1) CN1130365C (cs)
AT (1) ATE207071T1 (cs)
AU (1) AU735764B2 (cs)
BG (1) BG63975B1 (cs)
CA (1) CA2272330A1 (cs)
CY (1) CY2260B1 (cs)
CZ (1) CZ194499A3 (cs)
DE (1) DE69707497T2 (cs)
DK (1) DK0942911T3 (cs)
ES (1) ES2168682T3 (cs)
NO (1) NO992661L (cs)
NZ (1) NZ335711A (cs)
PT (1) PT942911E (cs)
SK (1) SK283580B6 (cs)
TR (1) TR199901883T2 (cs)
WO (1) WO1998024791A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1023278A1 (en) * 1997-10-10 2000-08-02 Abbott Laboratories Process for preparing substituted pyrazine compounds
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
AU759199B2 (en) * 1998-10-06 2003-04-10 Janssen Pharmaceutica N.V. Tricyclic delta3-piperidines as pharmaceuticals
US6172260B1 (en) * 1998-12-31 2001-01-09 Eastman Kodak Company Preparation of high dye-yield couplers and intermediates useful therein
AR022230A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
US20060128719A1 (en) * 2004-12-13 2006-06-15 Boehringer Ingelheim Pharmaceuticals, Inc. Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
WO2020081624A1 (en) * 2018-10-17 2020-04-23 Austin Research Labs, Corp. Suspension formulations of high load dispersions
CN110759878B (zh) * 2019-10-29 2021-04-09 西安瑞联新材料股份有限公司 一种苯基四氢呋喃醚类化合物的合成方法
TW202400018A (zh) * 2022-06-21 2024-01-01 日商組合化學工業股份有限公司 使用鹵乙酸之碸衍生物的製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
US4117140A (en) * 1975-02-10 1978-09-26 Brown Richard E Bronchodilating piperidinoethyl benzopyranopyridinones
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0942911A1 (en) 1999-09-22
ATE207071T1 (de) 2001-11-15
AU5516998A (en) 1998-06-29
JP2002504088A (ja) 2002-02-05
CA2272330A1 (en) 1998-06-11
EP0942911B1 (en) 2001-10-17
CZ194499A3 (cs) 1999-11-17
DE69707497T2 (de) 2002-07-11
BG103553A (en) 2000-06-30
ES2168682T3 (es) 2002-06-16
KR20000057418A (ko) 2000-09-15
PT942911E (pt) 2002-04-29
NZ335711A (en) 2000-10-27
CN1246861A (zh) 2000-03-08
CY2260B1 (en) 2003-07-04
DK0942911T3 (da) 2002-12-02
CN1130365C (zh) 2003-12-10
TR199901883T2 (xx) 1999-12-21
WO1998024791A1 (en) 1998-06-11
DE69707497D1 (de) 2001-11-22
NO992661D0 (no) 1999-06-02
SK283580B6 (sk) 2003-09-11
SK71799A3 (en) 2000-01-18
AU735764B2 (en) 2001-07-12
NO992661L (no) 1999-07-30

Similar Documents

Publication Publication Date Title
EP0808318B1 (en) Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
JP2021130712A (ja) Ｔｙｋ２阻害剤およびその使用
US5891882A (en) Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
AU2007352397B2 (en) Viral inhibitors
CA2935071A1 (en) Piperidine-dione derivatives
PT805812E (pt) Antagonistas alfa-1-adrenergicos de hexa-hidrobenz¬e|isoindolo biciclicos substituidos
EP2430029A1 (en) Thieno [2, 3-b]pyridine derivatives as viral replication inhibitors
KR20130086520A (ko) 스피로시클릭 화합물 및 이들의 치료제 및 진단 프로브로서 용도
US9765056B2 (en) Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
WO2021055621A1 (en) Plasma kallikrein inhibitors and uses thereof
JP6805172B2 (ja) ヒストンデアセチラーゼ阻害薬及び組成物並びにそれらの使用の方法
PT2356123E (pt) Espiro-5,6-di-hidro-4h-2,3,5,10b-tetra-azabenzo[ e]azulenos
IL311024A (en) Modified tricyclic compounds as PARP inhibitors and their use
TW202019939A (zh) 作為ｔｒｋ抑制劑的雜環化合物
BG63975B1 (bg) Бензопиранопиролови и бензопиранопиридинови алфа-1 адренергични съединения
CA3191001A1 (en) Synthesis of quinazoline compounds
CN117561058A (zh) Cdk2抑制剂及其使用方法
CN112321590A (zh) 咪唑并[2,1-f][1,2,4]三嗪-4-胺衍生物作为tlr8激动剂
DE69622677T2 (de) Hemmer der Prolaktinsynthese
US5175158A (en) Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
CN112028891A (zh) 腺苷受体拮抗剂
US5276025A (en) Heterobicyclic sulfonamides
TW202214634A (zh) 雜環化合物及其衍生物
JP2022554385A (ja) Ｗｄｒ５阻害剤及び調節剤
EP4434986A1 (en) 15-pgdh inhibitor and use thereof